D61.1

Drug-induced aplastic anemia

Risk-adjusting (HCC)Billable code

HCC risk adjustment mapping

CMS-HCC ESRD V24

HCC46

Severe Hematological Disorders

RxHCC V08

RXHCC96

Acquired Hemolytic, Aplastic, and Sideroblastic Anemias

Coding notes

Excludes 1 never coded together · Excludes 2 may co-exist

This code · D61.1

Use additional

code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)

Inherited from D61Oth aplastic anemias and other bone marrow failure syndromes

Excludes 2

neutropenia (D70.-)

Inherited from chapter 3Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

Excludes 2

autoimmune disease (systemic) NOS (M35.9) certain conditions originating in the perinatal period (P00-P96) complications of pregnancy, childbirth and the puerperium (O00-O9A) congenital malformations, deformations and chromosomal abnormalities (Q00-Q99) endocrine, nutritional and metabolic diseases (E00-E88) human immunodeficiency virus [HIV] disease (B20) injury, poisoning and certain other consequences of external causes (S00-T88) neoplasms (C00-D49) symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)

Official Guidelines for D61.1

FY 2026 ›

I.C.3Chapter-specific guidanceChapter 3: Disease of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89)

Find D61.1 in the alphabetic index

2 index paths lead to this code